Skip to main content
UniHealth

Doctor search

Bogdana Schmidt, MD

Urology · Salt Lake City

NPI 1386987865

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · University of Utah Adult Services · 1,758 clinicians in this group

Looking this up.

Hospitals listed: Memorial Hospital Sweetwater County · University of Utah Hospital and Clinics. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Schmidt’s office at (801) 581-8793 to ask if they take your plan before you enroll.

California Medical Board record

Licence A133342 · Delinquent

Licence status: Delinquent · since 2014 · expires 2022-04-30 · University of California San Francisco School of Medicine.

License renewal fee has not been paid. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Memorial Hospital Sweetwater CountyRock Springs, WYCritical Access Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPatients rate it 4 of 5 · 63% would definitely recommend it
    No overall ratingNo measure marked better or worse than the national rate
  • University of Utah Hospital and ClinicsSalt Lake City, UTAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of Utah Hospitals and Clinics, which runs 2 hospitalsHome of Huntsman Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.603, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.55, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.518, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.595, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.8 (7.3 to 10.3) · 1,119 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Memorial Hospital Sweetwater County
Every scored measure at Memorial Hospital Sweetwater County
Death rate for COPD patientsComplications and deaths9.7 · 49 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10 · 96 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.5 · 108 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12.6 · 25 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths4 · 324 casesNoneJul 2024 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 81 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17.5 · 103 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-28.7 · 107 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.5 · 86 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.3 to 7.7) · 78 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9 (6.2 to 12.8) · 78 casesNo differentJan 2024 – Dec 2024
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.4 · 47 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.6 (9.3 to 16.6) · 278 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.3) · 220 casesNo differentJan 2024 – Dec 2024

What patients said (181 patients answered, 17% of those asked)

Patient survey stars by topic at Memorial Hospital Sweetwater County
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Memorial Hospital Sweetwater County
Room was "always" clean75%
Nurses "always" communicated well81%
Doctors "always" communicated well81%
Staff "always" explained65%
Yes, staff "did" give patients this information90%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand77%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)69%
Staff "always" explained new medications79%
Nurses "always" explained things so they could understand76%
Nurses "always" listened carefully77%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night56%
"YES", patients would definitely recommend the hospital63%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms94%
See every measure and the patient survey for University of Utah Hospital and Clinics

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at University of Utah Hospital and Clinics
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.603BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.55BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.518BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.595BetterOct 2024 – Sep 2025
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits8.8 (7.3 to 10.3) · 1,119 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.78 (0.03 to 1.53) · 3,231 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.91 (0.6 to 1.22)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths156.56 (123.99 to 189.13) · 297 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.8 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.3 · 69 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12 · 168 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.1 · 423 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.7 · 347 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.8 · 506 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,004 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0.02 to 0.37) · 11,361 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.26 (0.08 to 0.43) · 12,089 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.06 (2.7 to 5.41) · 4,881 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.58 (0 to 3.27) · 204 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.55 (1.5 to 3.59) · 4,443 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.76 (0 to 15.4) · 212 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.49 (1.4 to 9.58) · 198 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.88 (0.63 to 3.14) · 1,317 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.5 (0.08 to 0.92) · 10,150 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths2.8 · 289 casesNoneApr 2023 – Mar 2025
SSI - Abdominal HysterectomyInfections0.204No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.738No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.5 · 213 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits17.5 · 664 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits0.4 · 180 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-34.8 · 478 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-7 · 374 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.2 · 535 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.8 (4.6 to 7) · 1,119 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.4 · 310 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10 · 72 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.2 · 113 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.6 (9.9 to 15.8) · 2,684 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.9 to 1.2) · 2,156 casesNo differentJan 2024 – Dec 2024

What patients said (1,497 patients answered, 27% of those asked)

Patient survey stars by topic at University of Utah Hospital and Clinics
Cleanliness4
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness4
Recommend hospital5
Share of patients giving the best answer at University of Utah Hospital and Clinics
Room was "always" clean79%
Nurses "always" communicated well79%
Doctors "always" communicated well78%
Staff "always" explained59%
Yes, staff "did" give patients this information90%
Yes, staff "did" give patients information about help after discharge91%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully77%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)78%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night61%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$91,573

Medicare paid this office $91,573 for 187 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Surgical removal of prostate and surrounding lymph nodes using an endoscope17$15,168$892
New patient visit (60+ min)42$5,170$123
Return visit (30+ min)40$4,833$90
Return visit (30+ min)48$4,556$70
Diagnostic exam of bladder and urethra using an endoscope38$4,401$55
See all 10 services
Every Original Medicare service billed
Surgical removal of prostate and surrounding lymph nodes using an endoscope17$15,168$892
New patient visit (60+ min)42$5,170$123
Return visit (30+ min)40$4,833$90
Return visit (30+ min)48$4,556$70
Diagnostic exam of bladder and urethra using an endoscope38$4,401$55
Long return visit (40+ min)30$3,384$97
Removal of lymph nodes of both sides of pelvis using an endoscope12$3,071$256
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm12$2,894$223
New patient visit (60+ min)17$2,769$163
Insertion of stent in ureter using an endoscope12$1,212$101

Procedures Medicare counted

Procedure volume Medicare published
Prostate resection17More than 74% of doctors who do this

Who their Medicare patients are

187 Original Medicare patients in 2024. Average age 73 · Women 19% · Also on Medicaid 8% · Health risk score 1.50. Above the middle of the specialty; the typical urology clinician is at 1.36.

Conditions among them: Cancer 70% · High blood pressure 63% · Diabetes 27% · Chronic kidney disease 27% · Coronary heart disease 21% · Depression 20% · Atrial fibrillation 17% · Heart failure 14% · COPD 13%.

The office billed $482,913, Medicare allowed $118,505 and paid $91,573; for 495 services of 50 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024187495731.50$482,913$91,573
2023157361731.46$303,631$60,386
2022119289721.76$311,723$62,129
20213158740.97$48,451$9,292
20201829732.72$192,968$3,306

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
New patient visit (60+ min)43$5,639$131
Long return visit (40+ min)39$3,880$97
Return visit (30+ min)44$3,746$67
Diagnostic exam of bladder and urethra using an endoscope28$2,485$54
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm11$2,219$202
Return visit (30+ min)18$1,523$69

2022: 6 services

Original Medicare services billed in 2022
Surgical removal of prostate and surrounding lymph nodes using an endoscope12$13,291$1,108
Long return visit (40+ min)49$7,269$110
New patient visit (60+ min)39$5,095$131
Removal of lymph nodes of both sides of pelvis using an endoscope12$3,101$258
Diagnostic exam of bladder and urethra using an endoscope18$1,559$58
Return visit (30+ min)15$1,146$64

2021: 1 service

Original Medicare services billed in 2021
New patient visit (60+ min)15$2,162$144

Medicaid work

$0 in 2018

Medicaid paid $0 for 56 billed services this clinician did in 2018, up to 28 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2018
Return visit (30+ min)56$0
Medicaid work by year
201856128$0

Drugs they prescribed that Part D paid

$14,531

Pharmacies billed $14,531 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

96 generic and 29 brand-name prescriptions · $14,531 in drug cost · 12 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Myrbetriq16$7,319$457
Eliquis11$5,228$475
Tamsulosin23$168$7
Oxybutynin Chloride14$44$3

Year by year

Part D prescribing by year
202412547None23%$14,531
20239641NoneNone$8,335
20226122NoneNone$4,085
20195224None37%$7,195
20184522None29%$6,287
2017211771% (15)None$289
20161004013% (13)None$4,909
201515761None13%$5,484

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Methenamine Hippurate13$1,073$83
Tamsulosin24$513$21
Finasteride11$166$15

2022: 1 drug

Part D drugs prescribed in 2022
Tamsulosin19$382$20

2019: 1 drug

Part D drugs prescribed in 2019
Myrbetriq12$4,452$371

2017: 1 drug

Part D drugs prescribed in 2017
Hydrocodone-Acetaminophen11$64$6

2016: 2 drugs

Part D drugs prescribed in 2016
Tamsulosin24$707$29
Finasteride16$175$11

2015: 3 drugs

Part D drugs prescribed in 2015
Tamsulosin38$1,261$33
Finasteride25$371$15
Ciprofloxacin27$87$3

Money from drug and device companies

$18,348 in 2025

Industry payments by year
2025627$15,598$18,348
2024537$10,050$16,795
202346None$420
202245None$312
202111None$119

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Ferring PharmaceuticalsAdstiladrin$11,534
11 payments
  • Consulting for Adstiladrin · 2025-12-22 · $8,075
  • Travel for Adstiladrin · 2025-12-13 · $117
  • Meals for Adstiladrin · 2025-12-13 · $32
  • Meals for Adstiladrin · 2025-12-13 · $39
  • Meals for Adstiladrin · 2025-12-12 · $76
  • Consulting for Adstiladrin · 2025-11-14 · $2,850
  • Meals for Adstiladrin · 2025-11-03 · $43
  • Meals for Adstiladrin · 2025-08-16 · $41
  • Meals for Adstiladrin · 2025-04-28 · $57
  • Meals for Adstiladrin · 2025-04-22 · $98
  • Meals for Adstiladrin · 2025-02-15 · $105
Janssen Global ServicesNone$3,084
3 payments
  • Meals · 2025-12-05 · $47
  • Consulting · 2025-12-05 · $2,538
  • Consulting · 2025-04-16 · $500
Intuitive SurgicalDa Vinci Sp$1,659
5 payments
  • Meals for Da Vinci Surgical System · 2025-03-18 · $90
  • Meals for Da Vinci Surgical System · 2025-03-18 · $3
  • Meals for Da Vinci Surgical System · 2025-03-18 · $52
  • Meals for Da Vinci Surgical System · 2025-02-04 · $14
  • Education for Da Vinci Sp · 2025-01-17 · $1,500
Janssen Scientific AffairsNone$1,031
4 payments
  • Meals · 2025-12-04 · $47
  • Meals · 2025-04-27 · $150
  • Consulting · 2025-04-27 · $818
  • Meals · 2025-04-27 · $17
Janssen BiotechErleada$965
3 payments
  • Consulting · 2025-04-27 · $818
  • Meals for Erleada · 2025-04-25 · $24
  • Meals for Erleada · 2025-04-25 · $124
ColoplastAltis$76
1 payment
  • Meals for Altis · 2025-10-14 · $76
See all 27 published payments
Every published payment
Ferring PharmaceuticalsConsulting · 2025-12-22Adstiladrin$8,075
Ferring PharmaceuticalsTravel · 2025-12-13Adstiladrin$117
Ferring PharmaceuticalsMeals · 2025-12-13Adstiladrin$32
Ferring PharmaceuticalsMeals · 2025-12-13Adstiladrin$39
Ferring PharmaceuticalsMeals · 2025-12-12Adstiladrin$76
Janssen Global ServicesMeals · 2025-12-05None$47
Janssen Global ServicesConsulting · 2025-12-05None$2,538
Janssen Scientific AffairsMeals · 2025-12-04None$47
Ferring PharmaceuticalsConsulting · 2025-11-14Adstiladrin$2,850
Ferring PharmaceuticalsMeals · 2025-11-03Adstiladrin$43
ColoplastMeals · 2025-10-14Altis$76
Ferring PharmaceuticalsMeals · 2025-08-16Adstiladrin$41
Ferring PharmaceuticalsMeals · 2025-04-28Adstiladrin$57
Janssen Scientific AffairsMeals · 2025-04-27None$150
Janssen Scientific AffairsConsulting · 2025-04-27None$818
Janssen Scientific AffairsMeals · 2025-04-27None$17
Janssen BiotechConsulting · 2025-04-27None$818
Janssen BiotechMeals · 2025-04-25Erleada$24
Janssen BiotechMeals · 2025-04-25Erleada$124
Ferring PharmaceuticalsMeals · 2025-04-22Adstiladrin$98
Janssen Global ServicesConsulting · 2025-04-16None$500
Intuitive SurgicalMeals · 2025-03-18Da Vinci Surgical System$90
Intuitive SurgicalMeals · 2025-03-18Da Vinci Surgical System$3
Intuitive SurgicalMeals · 2025-03-18Da Vinci Surgical System$52
Ferring PharmaceuticalsMeals · 2025-02-15Adstiladrin$105
Intuitive SurgicalMeals · 2025-02-04Da Vinci Surgical System$14
Intuitive SurgicalEducation · 2025-01-17Da Vinci Sp$1,500
See earlier years (2024, 2023, 2022, 2021)

2024: $16,795

Payments by company in 2024
Ferring PharmaceuticalsAdstiladrin$7,111
9 payments
  • Paid to speak or teach for Adstiladrin · 2024-12-19 · $2,700
  • Meals for Adstiladrin · 2024-12-06 · $80
  • Meals · 2024-12-06 · $53
  • Paid to speak or teach for Adstiladrin · 2024-12-05 · $3,600
  • Travel for Adstiladrin · 2024-12-03 · $74
  • Meals for Adstiladrin · 2024-12-03 · $39
  • Travel for Adstiladrin · 2024-12-03 · $522
  • Meals for Adstiladrin · 2024-11-19 · $21
  • Meals for Adstiladrin · 2024-08-24 · $22
Intuitive SurgicalDa Vinci Surgical System$5,541
22 payments
  • Travel for Da Vinci Surgical System · 2024-12-27 · $80
  • Travel for Da Vinci Surgical System · 2024-12-27 · $92
  • Meals for Da Vinci Surgical System · 2024-12-27 · $100
  • Travel for Da Vinci Surgical System · 2024-12-17 · $91
  • Meals for Da Vinci Surgical System · 2024-12-17 · $9
  • Meals for Da Vinci Surgical System · 2024-12-17 · $30
  • Meals for Da Vinci Surgical System · 2024-11-12 · $57
  • Meals for Da Vinci Surgical System · 2024-11-12 · $6
  • Meals for Da Vinci Surgical System · 2024-11-12 · $4
  • Meals for Da Vinci Surgical System · 2024-11-12 · $10
  • Education for Da Vinci Sp · 2024-11-12 · $2,500
  • Travel for Da Vinci Surgical System · 2024-11-12 · $204
  • Meals for Da Vinci Surgical System · 2024-11-12 · $18
  • Meals for Da Vinci Surgical System · 2024-11-12 · $17
  • Travel for Da Vinci Surgical System · 2024-10-23 · $19
  • Travel for Da Vinci Surgical System · 2024-10-23 · $978
  • Travel for Da Vinci Surgical System · 2024-10-14 · $129
  • Travel for Da Vinci Surgical System · 2024-09-25 · $978
  • Travel for Da Vinci Surgical System · 2024-09-25 · $19
  • Meals for Da Vinci Surgical System · 2024-07-23 · $18
  • Travel for Da Vinci Surgical System · 2024-04-24 · $163
  • Travel for Da Vinci Surgical System · 2024-04-24 · $19
Urogen PharmaJelmyto$3,937
3 payments
  • Honoraria for Jelmyto · 2024-12-05 · $3,750
  • Meals for Jelmyto · 2024-12-05 · $151
  • Meals for Jelmyto · 2024-12-05 · $36
ColoplastTitan$125
1 payment
  • Meals for Titan · 2024-10-01 · $125
Boston ScientificLithovue$81
2 payments
  • Meals for Lithovue · 2024-11-11 · $68
  • Meals for Tria Firm · 2024-02-02 · $13

2023: $420

Payments by company in 2023
Janssen Research & DevelopmentNone$180
3 payments
  • Meals · 2023-11-29 · $60
  • Meals · 2023-11-29 · $60
  • Meals · 2023-11-29 · $60
Fennec PharmaceuticalsPedmark$137
1 payment
  • Meals for Pedmark · 2023-04-29 · $137
ColoplastTitan$68
1 payment
  • Meals for Titan · 2023-10-03 · $68
TeleflexUrolift$36
1 payment
  • Meals for Urolift · 2023-10-02 · $36

2022: $312

Payments by company in 2022
UroGen PharmaJelmyto$150
1 payment
  • Meals for Jelmyto · 2022-05-13 · $150
Janssen Research & DevelopmentNone$100
2 payments
  • Meals · 2022-01-12 · $50
  • Meals · 2022-01-12 · $50
Boston ScientificAms 700 Cxr Rte Kit$33
1 payment
  • Meals for Ams 700 Cxr Rte Kit · 2022-11-14 · $33
Myriad Genetic LaboratoriesProlaris$29
1 payment
  • Meals for Prolaris · 2022-11-01 · $29

2021: $119

Payments by company in 2021
Boston ScientificGeneral Kidney Stone Disease$119
1 payment
  • Meals for General Kidney Stone Disease · 2021-11-02 · $119

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Janssen Research & Development, LLC · 2023Their institution$100,169
Janssen Research & Development, LLC · A Study of Tar-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (Sunrise-4) · 2025Their institution$82,522
Janssen Research & Development, LLC · 2024Their institution$57,600
Janssen Research & Development, LLC · A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of Tar-200 in Combination With Cetrelimab Versus Intravesical Bacillus Calmettegurin (Bcg) in Participants With Bcg-Nave High-Risk Non-Muscle Invasive Bladder Canc · 2024Their institution$41,146
Ferring Pharmaceuticals AS · Adstiladrin Early Utilization and Outcomes in the Real World Setting in the United States · 2025Their institution$20,726
Janssen Research & Development, LLC · A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of Tar-200 in Combination With Cetrelimab Versus Intravesical Bacillus Calmettegu?Rin (Bcg) in Participants With Bcg-Na?Ve High-Risk Non-Muscle Invasive Bladder Canc · 2023Their institution$20,000
Janssen Research & Development, LLC · A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of Tar-200 in Combination With Cetrelimab Versus Intravesical Bacillus Calmettegurin (Bcg) in Participants With Bcg-Nave High-Risk Non-Muscle Invasive Bladder Canc · 2025Their institution$3,743

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
92.1 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1386987865
Licence
CA A133342California A133342: Delinquent · expires 2022-04-30
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Urology (208800000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2013-04-03
NPI last updated
2021-11-18
NPI record certified
2021-11-18

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.